Network-based identification of key master regulators associated with an immune-silent cancer phenotype حسب Raghvendra Mall (581171)

"…However, in some cancers, such an intratumoral immune activation does not confer protection from progression or relapse. Defining mechanisms associated with immune evasion is imperative to refine stratification algorithms, to guide treatment decisions and to identify candidates for immune-targeted therapy. …"